Associated Papers
KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways.
Mondal K et al.
Cells, 2024
Blockade of mutant RAS oncogenic signaling with a special emphasis on KRAS.
Roskoski R
Pharmacological Research, 2021
Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
Shen J et al.
Oncogene, 2016
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.
Aziz SA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2009
Select a paper to view details